News - Vaccines, Tropical diseases

Filter

Current filters:

VaccinesTropical diseases

Popular Filters

New malaria vaccines roadmap targets next generation products by 2030

New malaria vaccines roadmap targets next generation products by 2030

14-11-2013

The world should aim to have vaccines which reduce malaria cases by 75%, and are capable of eliminating…

HealthcarePharmaceuticalResearchRest of the WorldTropical diseasesVaccines

Vaccine confers long-term protection against cholera

17-10-2013

A clinical study published in the Lancet Infectious Diseases demonstrates for the first time that an…

PharmaceuticalSanofiShanthaTropical diseasesVaccines

New data support GSK plan to file for approval of malaria vaccine in 2014

New data support GSK plan to file for approval of malaria vaccine in 2014

08-10-2013

Results from a large-scale Phase III trial, presented today at the Multilateral Initiative on Malaria…

GlaxoSmithKlinePharmaceuticalRegulationResearchRTS,STropical diseasesVaccines

Novartis licenses technology to India's BioE to deliver affordable typhoid vaccines

08-07-2013

Swiss pharma major Novartis (NOVN: VX) said this morning (July 8) that it has entered into a development…

Biological E LtdLicensingNovartisPharmaceuticalResearchTropical diseasesVaccines

PATH MVI links with Inovio on malaria vaccines and delivery technology

07-01-2013

The USA-based PATH Malaria Vaccine Initiative (MVI) has announced a follow-on collaboration with drugmaker…

Inovio PharmaceuticalsPharmaceuticalResearchTropical diseasesVaccines

Eisai's Fycompa gets first EU launch, in UK; links with Sabine Vaccine Inst

13-09-2012

Japanese drug major Eisai (TYO: 4523) has announced the first European launch today of Fycompa (perampanel),…

EisaiFycompaMarkets & MarketingNeurologicalPharmaceuticalResearchTropical diseasesVaccines

Sanofi Pasteur's dengue vaccine proves effective and safe; FDA identifies cGMP deviations

25-07-2012

French drug major Sanofi (Euronext: SAN) vaccines subsidiary Sanofi Pasteur sais this morning that its…

PharmaceuticalRegulationResearchSanofiSanofi PasteurTropical diseasesVaccines

Novavax and Cadila in public/private malaria vaccine collaboration

17-07-2012

USA-based clinical-stage firm Novavax (Nasdaq: NVAX), CPL Biologicals (CPLB) - a joint-venture biotechnology…

Cadila PharmaceuticalsCPL BiologicalsNovavaxPharmaceuticalResearchTropical diseasesVaccines

Back to top